1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Glioma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Akhlaghi, M; Biabani Ardakani, J; Hosseinimehr, SJ; Molavipordanjani, S; Nikkholgh, B; Ranjbar, V | 1 |
| Abrahmsen, L; Eriksson, O; Orlova, A; Strand, J; Tolmachev, V; Varasteh, Z | 1 |
| Arteaga de Murphy, C; Avila-Rodriguez, MA; Ferro-Flores, G; Gaspar-Carcamo, RE; Lopez-Rodriguez, V; Pedraza-Lopez, M; Rojas-Calderon, EL | 1 |
| Hayashi, Y; Iguchi, Y; Kitamatsu, M; Matsui, H; Michiue, H; Nishiki, T; Takenaka, F | 1 |
| Echner, H; Gharabaghi, A; Heckl, S; Kalbacher, H; Klose, U; Regenbogen, M; Sturzu, A | 1 |
| Chen, X; Kim, YS; Liu, S; Liu, Z; Shi, J; Zhai, S | 1 |
| Heckl, S; Sturzu, A | 1 |
| Apostolidis, C; Bruchertseifer, F; Cordier, D; Forrer, F; Good, S; Mäcke, H; Merlo, A; Morgenstern, A; Müller-Brand, J; Reubi, JC | 1 |
| Chakraborty, S; Jia, B; Kim, YS; Liu, S; Shi, J; Wang, F; Zhou, Y | 1 |
| Bigner, DD; Hens, M; Vaidyanathan, G; Zalutsky, MR; Zhao, XG | 1 |
| Hong, MK; Jeong, JM; Kim, SE; Kim, YJ; Lee, JJ; Lee, YS; Shetty, D; Son, JY | 1 |
| Kjaer, A; Madsen, J; Persson, M; Ploug, M; Østergaard, S | 1 |
| Beck, A; Echner, H; Feil, G; Gharabaghi, A; Heckl, S; Nagele, T; Regenbogen, M; Sturzu, A | 1 |
1 trial(s) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Glioma
| Article | Year |
|---|---|
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial.
Topics: Adult; Alpha Particles; Feasibility Studies; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Injections; Middle Aged; Organometallic Compounds; Pilot Projects; Substance P; Treatment Outcome | 2010 |
12 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Glioma
| Article | Year |
|---|---|
Initial preclinical evaluation of 68 Ga-DOTA-(Ser) 3 -LTVSPWY peptide as a PET radiotracer for glioblastoma targeting and imaging.
Topics: Animals; Cell Line, Tumor; Gallium Radioisotopes; Glioblastoma; Glioma; Heterocyclic Compounds, 1-Ring; Mice; Oligopeptides; Peptides; Positron-Emission Tomography; Tissue Distribution | 2022 |
Gallium-68-labeled affibody molecule for PET imaging of PDGFRβ expression in vivo.
Topics: Animals; Antibodies, Monoclonal; Brain Neoplasms; Cell Line, Tumor; Female; Gallium Radioisotopes; Glioma; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Multimodal Imaging; Neoplasm Transplantation; Neovascularization, Pathologic; Positron-Emission Tomography; Receptor, Platelet-Derived Growth Factor beta; Tomography, X-Ray Computed | 2014 |
Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Gallium Radioisotopes; Glioma; Heterocyclic Compounds, 1-Ring; Integrin alphaVbeta3; Mice; Peptides, Cyclic; Positron-Emission Tomography; Radiochemistry; Radiometry; Radiopharmaceuticals; Rats; Tissue Distribution | 2015 |
Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
Topics: Animals; Arginine; Boron; Boron Neutron Capture Therapy; Boronic Acids; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Copper; Disease Models, Animal; Drug Delivery Systems; Female; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Peptides; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Novel cell nucleus directed fluorescent tetraazacyclododecane-tetra-acetic acid compounds.
Topics: Active Transport, Cell Nucleus; Antigens, Polyomavirus Transforming; Cell Nucleus; Cell Survival; Cytoplasm; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glioma; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Microscopy, Confocal; Nuclear Localization Signals; Organometallic Compounds; Peptides; Spectrometry, Mass, Electrospray Ionization; tat Gene Products, Human Immunodeficiency Virus | 2009 |
Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers.
Topics: Animals; Copper Radioisotopes; Dimerization; Gene Expression Regulation, Neoplastic; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Mice; Neoplasms; Oligopeptides; Peptides, Cyclic; Polyethylene Glycols; Positron-Emission Tomography; Radiochemistry; Staining and Labeling; Tissue Distribution; Transplantation, Heterologous | 2009 |
Magnetic resonance imaging of human glioma cells by means of an interleukin-6 receptor-targeted contrast agent.
Topics: Cell Line, Tumor; Contrast Media; Coordination Complexes; Fluorescent Dyes; Gadolinium; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Ligands; Magnetic Resonance Imaging; Receptors, Interleukin-6; Rhodamines | 2010 |
Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent.
Topics: Animals; Cell Line, Tumor; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Integrin alphaVbeta3; Mice; Mice, Nude; Oligopeptides; Peptides, Cyclic; Radionuclide Imaging | 2010 |
Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands.
Topics: Animals; Antibodies, Monoclonal; Brain Neoplasms; ErbB Receptors; Flow Cytometry; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Isothiocyanates; Lutetium; Mice; Mice, Inbred BALB C; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Stereoisomerism; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Evaluation of (111)In-labeled macrocyclic chelator-amino acid derivatives for cancer imaging.
Topics: Amino Acids; Aminobutyrates; Animals; Cell Line, Tumor; Chelating Agents; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Mice; Mice, Nude; Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous | 2012 |
68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
Topics: Acetates; Amides; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Drug Stability; Female; Gallium; Gallium Radioisotopes; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Mice; Neoplasm Invasiveness; Peptides; Positron-Emission Tomography; Protein Binding; Receptors, Urokinase Plasminogen Activator | 2012 |
Value of apoptin's 40-amino-acid C-terminal fragment for the differentiation between human tumor and non-tumor cells.
Topics: Amino Acid Sequence; Apoptosis; Astrocytes; Brain; Capsid Proteins; Cell Line, Tumor; Cell Nucleus; Cells, Cultured; Dansyl Compounds; Flow Cytometry; Fluorescein-5-isothiocyanate; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Male; Microscopy, Confocal; Microscopy, Fluorescence; Nuclear Export Signals; Nuclear Localization Signals; Peptide Fragments; Phosphothreonine; Prostate; Prostatic Neoplasms; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2008 |